Why the US Centers for Medicare and Medicaid Services (CMS) should have required a randomized trial of Foundation Medicine (F1CDx) before paying for it. (11th December 2017)

Record Type:: Journal Article
Title:: Why the US Centers for Medicare and Medicaid Services (CMS) should have required a randomized trial of Foundation Medicine (F1CDx) before paying for it. (11th December 2017)
Main Title:: Why the US Centers for Medicare and Medicaid Services (CMS) should have required a randomized trial of Foundation Medicine (F1CDx) before paying for it
Authors:: Prasad, V
Abstract:
Is Part Of:: Annals of oncology. Volume 29:Number 2(2018)
Journal:: Annals of oncology
Issue:: Volume 29:Number 2(2018)
Issue Display:: Volume 29, Issue 2 (2018)
Year:: 2018
Volume:: 29
Issue:: 2
Issue Sort Value:: 2018-0029-0002-0000
Page Start:: 298
Page End:: 300
Publication Date:: 2017-12-11
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx786 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12194.xml